CYSKLAR DIN 02566524
Health Canada record
| Active ingredient(s) | CYSTEAMINE HYDROCHLORIDE 0.44 % W/V |
|---|---|
| Dosage form | Solution |
| Route | Ophthalmic |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | S01XA21 MERCAPTAMINE |
| Original market date | |
| Current status date | 06-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Leadiant Biosciences, Inc. — licence 3-002460, currently licensed, last inspection rating C (2023-03-01).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37062 | 2026-03-06 | New Drug Submission (NDS) |